Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s): CRDL

Healthcare

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc

Bullboard Posts

Comment by NewFanCBDon Jul 08, 2020 11:47pm

60 Views

Post# 31243359

RE:RE:Uptrend coming?

Great points here. I hear you. Patience will be key here with Cardiol. The story is only going to get better. I would suggest tuning into the CBD BioPharma investor conference tomorrow at 11am go hear David Elsley speak. The Covid angle for me is a game Changer. Shoppers is getting ready for the onset of CatdiolRX. We will be fine here in time. $3.45 is coming!!

Bullboard Posts

Changing Europe’s dependency on HREE from China